Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Therapy01:28

Drug Therapy

44
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
44
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

201
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
201
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

259
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
259
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

131
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
131
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

721
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
721
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Towards Mechanism-Informed Treatments for Mental Health.

Journal of neurochemistry·2026
Same author

An international, double-blind, randomized, placebo-controlled clinical trial of adjunctive trimetazidine to treat people with bipolar depression (the TIDE trial) protocol.

BMC psychiatry·2026
Same author

The Candesartan Adjunctive Depression Trials-CADET: Study Protocols for Double-Blind, Randomized, Placebo-Controlled Trials for Bipolar Depression and Major Depressive Disorder.

Journal of clinical psychopharmacology·2026
Same author

Potential Impact of Childhood Abuse on Quality of Life During Mood-Stabilising Treatment in Individuals Living With Bipolar Disorder.

Bipolar disorders·2026
Same author

Melatonin in bipolar disorder.

Journal of affective disorders·2025
Same author

Investigating the role of melatonin in bipolar disorder using transcriptomics.

bioRxiv : the preprint server for biology·2025
Same journal

CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same journal

In memoriam: Jon Kar Zubieta, M.D., Ph.D.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same journal

Pharmacokinetics and concentration-behavioral effect relationships differ between brain subcompartments.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same journal

Auditory event-related potentials and psychosis dimensions.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same journal

Cultural humility in the teaching and practice of clinical care.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same journal

Kappa opioid receptors mediate aversion-and it matters.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
查看所有相关文章

相关实验视频

Updated: Jul 4, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

基于网络的药物重定向用于精神分裂症.

Trang T T Truong1, Zoe S J Liu1, Bruna Panizzutti1

  • 1Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
|February 6, 2024
PubMed
概括
此摘要是机器生成的。

通过分析基因调节网络,计算药物重定向通过分析基因调节网络,确定了18种潜在的精神分裂症治疗方法. 针对的关键途径包括能量代谢和免疫反应,像里莫纳班特这样的候选药物显示出承诺.

更多相关视频

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

164
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K

相关实验视频

Last Updated: Jul 4, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

164
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K

科学领域:

  • 计算神经科学是一种计算神经科学.
  • 基因组学就是基因组学.
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 精神分裂症药物发现面临着持续的挑战.
  • 计算药物重新定位通过利用广泛的生物医学数据库提供了一个有希望的途径.
  • 基因调节网络 (GRNs) 对于理解转录因子 (TF) 调节效应至关重要.

研究的目的:

  • 确定精神分裂症患者和健康对照者之间的TF基因调节网络的拓差异.
  • 为了利用这些差异进行计算药物重新定位,找到新的精神分裂症治疗方法.

主要方法:

  • 利用PANDA算法从RNA-seq数据 (CommonMind项目,532个样本) 中构建和分析TF基因调节网络.
  • 集成的结合基因,蛋白相互作用和基因共同表达数据.
  • 采用差异网络分析 (CLUEreg工具) 来识别针对疾病相关基因特征的候选药物.

主要成果:

  • 在精神分裂症病例和对照中为15831个基因和413个TF构建了GRNs.
  • 确定了18个有前途的药物重用候选人用于精神分裂症.
  • 与精神分裂症相关的TF主要调节能量代谢,免疫反应,细胞粘附和甲状腺激素信号传递的途径.

结论:

  • 药物重用候选人可能会准已识别的TF调节路径.
  • 里莫纳班特和凯姆菲罗尔被强调为候选药物,需要进一步研究.
  • 这种基于网络的方法为识别精神分裂症的新疗法目标提供了一个强大的策略.